---
title: "Correction to Chikungunya Virus Study Published in The Lancet Infectious Diseases"
id: "news-news-lancet-infectious-diseases-b0d91ef6ae173e3c32069a58"
canonical_url: "https://medichelpline.com/news/news-news-lancet-infectious-diseases-b0d91ef6ae173e3c32069a58"
content_type: "medical_news_article"
category: "Infectious Disease"
source_name: "The Lancet Infectious Diseases"
source_url: "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00083-6/fulltext?rss=yes"
published_at: "2026-02-13T23:30:01.000Z"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Correction to Chikungunya Virus Study Published in The Lancet Infectious Diseases
## Metadata & Source Attribution
- **Canonical URL:** https://medichelpline.com/news/news-news-lancet-infectious-diseases-b0d91ef6ae173e3c32069a58
- **Category:** [Infectious Disease](https://medichelpline.com/news/infectious-disease.md)
- **Reporting Source:** The Lancet Infectious Diseases
- **Original Source URL:** [Read Original Article](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00083-6/fulltext?rss=yes)
- **Published At:** 2026-02-13T23:30:01.000Z
## Executive Summary & Key Highlights
A correction to a study on chikungunya virus in Brazil has been issued, updating the mean case fatality ratio.
## In-Depth Reporting & Editorial Analysis
A correction has been issued for the article discussing the chikungunya virus epidemiology in Brazil and vaccine impact, published by Cortes-Azuero et al. in The Lancet Infectious Diseases. The revised text in the Results section now states, “the mean case fatality ratio (of confirmed cases) was 0·35% (95% CI 0·34–0·37).” This amendment was made to the online version on February 13, 2026, and will also appear in the printed edition.
## Navigation
- [← Back to Infectious Disease News](https://medichelpline.com/news/infectious-disease.md)
- [← All Medical News Categories](https://medichelpline.com/news.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.